APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hydromorphone

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hydromorphone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025195 pages

Choose your research edition.

Industry ResearchHydromorphone Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydromorphone Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Hydromorphone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydromorphone Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydromorphone Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Hydromorphone market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hydromorphone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hydromorphone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hydromorphone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hydromorphone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hydromorphone include Teva Pharmaceuticals, Johnson & Johnson, Novartis, Mylan, Pfizer, Fresenius, Watson Laboratories, Stada Arzneimittel and Purdue Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hydromorphone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hydromorphone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hydromorphone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hydromorphone market size, projected growth trends, production technologies, key applications, and end-use industries.

Hydromorphone Segment by Company

Teva Pharmaceuticals

Johnson & Johnson

Novartis

Mylan

Pfizer

Fresenius

Watson Laboratories

Stada Arzneimittel

Purdue Pharma

Mundipharma

Mallinckrodt

Lannett

KV Pharmaceutical

Barr Pharmaceuticals

Apotex

Akorn

Hydromorphone Segment by Type

Oral

Injection

Hydromorphone Segment by Application

Hospital

Drug Store

Hydromorphone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydromorphone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydromorphone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydromorphone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hydromorphone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hydromorphone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hydromorphone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hydromorphone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hydromorphone Industry Trends Table 2. Hydromorphone Industry Drivers Table 3. Hydromorphone Industry Opportunities and Challenges Table 4. Hydromorphone Industry Restraints Table 5. Global Hydromorphone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hydromorphone Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hydromorphone Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Hydromorphone Sales Market Share by Manufacturers Table 9. Global Hydromorphone Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Hydromorphone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hydromorphone Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hydromorphone Manufacturers, Product Type & Application Table 13. Global Hydromorphone Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hydromorphone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Table 17. Major Manufacturers of Injection Table 18. Global Hydromorphone Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Hydromorphone Sales by Type (2021-2026) & (K Units) Table 20. Global Hydromorphone Sales by Type (2027-2032) & (K Units) Table 21. Global Hydromorphone Sales Market Share by Type (2021-2026) Table 22. Global Hydromorphone Sales Market Share by Type (2027-2032) Table 23. Global Hydromorphone Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Hydromorphone Revenue by Type (2021-2026) & (K Units) Table 25. Global Hydromorphone Revenue by Type (2027-2032) & (K Units) Table 26. Global Hydromorphone Revenue Market Share by Type (2021-2026) Table 27. Global Hydromorphone Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Drug Store Table 30. Global Hydromorphone Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Hydromorphone Sales by Application (2021-2026) & (K Units) Table 32. Global Hydromorphone Sales by Application (2027-2032) & (K Units) Table 33. Global Hydromorphone Sales Market Share by Application (2021-2026) Table 34. Global Hydromorphone Sales Market Share by Application (2027-2032) Table 35. Global Hydromorphone Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Hydromorphone Revenue by Application (2021-2026) & (K Units) Table 37. Global Hydromorphone Revenue by Application (2027-2032) & (K Units) Table 38. Global Hydromorphone Revenue Market Share by Application (2021-2026) Table 39. Global Hydromorphone Revenue Market Share by Application (2027-2032) Table 40. Global Hydromorphone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Hydromorphone Sales by Region (2021-2026) & (K Units) Table 42. Global Hydromorphone Sales Market Share by Region (2021-2026) Table 43. Global Hydromorphone Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Hydromorphone Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Hydromorphone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Hydromorphone Sales by Country (2021-2026) & (K Units) Table 47. North America Hydromorphone Sales by Country (2027-2032) & (K Units) Table 48. Europe Hydromorphone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Hydromorphone Sales by Country (2021-2026) & (K Units) Table 50. Europe Hydromorphone Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Hydromorphone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Hydromorphone Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Hydromorphone Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Hydromorphone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Hydromorphone Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Hydromorphone Sales by Country (2027-2032) & (K Units) Table 57. Global Hydromorphone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Hydromorphone Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Hydromorphone Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Hydromorphone Revenue Market Share by Region (2021-2026) Table 61. Global Hydromorphone Revenue Market Share by Region (2027-2032) Table 62. Teva Pharmaceuticals Company Information Table 63. Teva Pharmaceuticals Business Overview Table 64. Teva Pharmaceuticals Hydromorphone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Teva Pharmaceuticals Hydromorphone Product Portfolio Table 66. Teva Pharmaceuticals Recent Development Table 67. Johnson & Johnson Company Information Table 68. Johnson & Johnson Business Overview Table 69. Johnson & Johnson Hydromorphone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Johnson & Johnson Hydromorphone Product Portfolio Table 71. Johnson & Johnson Recent Development Table 72. Novartis Company Information Table 73. Novartis Business Overview Table 74. Novartis Hydromorphone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Novartis Hydromorphone Product Portfolio Table 76. Novartis Recent Development Table 77. Mylan Company Information Table 78. Mylan Business Overview Table 79. Mylan Hydromorphone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Mylan Hydromorphone Product Portfolio Table 81. Mylan Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Hydromorphone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Pfizer Hydromorphone Product Portfolio Table 86. Pfizer Recent Development Table 87. Fresenius Company Information Table 88. Fresenius Business Overview Table 89. Fresenius Hydromorphone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Fresenius Hydromorphone Product Portfolio Table 91. Fresenius Recent Development Table 92. Watson Laboratories Company Information Table 93. Watson Laboratories Business Overview Table 94. Watson Laboratories Hydromorphone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Watson Laboratories Hydromorphone Product Portfolio Table 96. Watson Laboratories Recent Development Table 97. Stada Arzneimittel Company Information Table 98. Stada Arzneimittel Business Overview Table 99. Stada Arzneimittel Hydromorphone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Stada Arzneimittel Hydromorphone Product Portfolio Table 101. Stada Arzneimittel Recent Development Table 102. Purdue Pharma Company Information Table 103. Purdue Pharma Business Overview Table 104. Purdue Pharma Hydromorphone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Purdue Pharma Hydromorphone Product Portfolio Table 106. Purdue Pharma Recent Development Table 107. Mundipharma Company Information Table 108. Mundipharma Business Overview Table 109. Mundipharma Hydromorphone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Mundipharma Hydromorphone Product Portfolio Table 111. Mundipharma Recent Development Table 112. Mallinckrodt Company Information Table 113. Mallinckrodt Business Overview Table 114. Mallinckrodt Hydromorphone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Mallinckrodt Hydromorphone Product Portfolio Table 116. Mallinckrodt Recent Development Table 117. Lannett Company Information Table 118. Lannett Business Overview Table 119. Lannett Hydromorphone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Lannett Hydromorphone Product Portfolio Table 121. Lannett Recent Development Table 122. KV Pharmaceutical Company Information Table 123. KV Pharmaceutical Business Overview Table 124. KV Pharmaceutical Hydromorphone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. KV Pharmaceutical Hydromorphone Product Portfolio Table 126. KV Pharmaceutical Recent Development Table 127. Barr Pharmaceuticals Company Information Table 128. Barr Pharmaceuticals Business Overview Table 129. Barr Pharmaceuticals Hydromorphone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Barr Pharmaceuticals Hydromorphone Product Portfolio Table 131. Barr Pharmaceuticals Recent Development Table 132. Apotex Company Information Table 133. Apotex Business Overview Table 134. Apotex Hydromorphone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Apotex Hydromorphone Product Portfolio Table 136. Apotex Recent Development Table 137. Akorn Company Information Table 138. Akorn Business Overview Table 139. Akorn Hydromorphone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Akorn Hydromorphone Product Portfolio Table 141. Akorn Recent Development Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Hydromorphone Distributors List Table 145. Hydromorphone Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Hydromorphone Product Image Figure 2. Global Hydromorphone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydromorphone Market Size (2021-2032) & (US$ Million) Figure 4. Global Hydromorphone Sales (2021-2032) & (K Units) Figure 5. Global Hydromorphone Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hydromorphone Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Image Figure 9. Injection Image Figure 10. Global Hydromorphone Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Hydromorphone Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Hydromorphone Sales Market Share by Type (2021-2032) Figure 13. Global Hydromorphone Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Hydromorphone Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hydromorphone Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Drug Store Image Figure 18. Global Hydromorphone Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Hydromorphone Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Hydromorphone Sales Market Share by Application (2021-2032) Figure 21. Global Hydromorphone Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Hydromorphone Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Hydromorphone Revenue Market Share by Application (2021-2032) Figure 24. North America Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Hydromorphone Sales Market Share by Country (2021-2032) Figure 26. U.S. Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Hydromorphone Sales Market Share by Country (2021-2032) Figure 31. Germany Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Hydromorphone Sales Market Share by Country (2021-2032) Figure 38. China Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Hydromorphone Sales Market Share by Country (2021-2032) Figure 46. Brazil Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Hydromorphone Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Hydromorphone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Hydromorphone Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Hydromorphone Revenue (2021-2032) & (US$ Million) Figure 57. North America Hydromorphone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Hydromorphone Revenue (2021-2032) & (US$ Million) Figure 59. Europe Hydromorphone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Hydromorphone Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Hydromorphone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Hydromorphone Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Hydromorphone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Hydromorphone Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Hydromorphone Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Hospital
  • Drug Store
Companies covered
  • Teva Pharmaceuticals
  • Johnson & Johnson
  • Novartis
  • Mylan
  • Pfizer
  • Fresenius
  • Watson Laboratories
  • Stada Arzneimittel
  • Purdue Pharma
  • Mundipharma
  • Mallinckrodt
  • Lannett
  • KV Pharmaceutical
  • Barr Pharmaceuticals
  • Apotex
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hydromorphone Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hydromorphone Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hydromorphone Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hydromorphone Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hydromorphone Market Dynamics
  1. 2.1 Hydromorphone Industry Trends
  2. 2.2 Hydromorphone Industry Drivers
  3. 2.3 Hydromorphone Industry Opportunities and Challenges
  4. 2.4 Hydromorphone Industry Restraints
3 Hydromorphone Market by Manufacturers
  1. 3.1 Global Hydromorphone Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hydromorphone Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hydromorphone Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hydromorphone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hydromorphone Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hydromorphone Manufacturers, Product Type & Application
  7. 3.7 Global Hydromorphone Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hydromorphone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hydromorphone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hydromorphone Tier 1, Tier 2, and Tier 3
4 Hydromorphone Market by Type
  1. 4.1 Hydromorphone Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Injection
  4. 4.2 Global Hydromorphone Sales by Type
  5. 4.2.1 Global Hydromorphone Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hydromorphone Sales by Type (2021-2032)
  7. 4.2.3 Global Hydromorphone Sales Market Share by Type (2021-2032)
  8. 4.3 Global Hydromorphone Revenue by Type
  9. 4.3.1 Global Hydromorphone Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hydromorphone Revenue by Type (2021-2032)
  11. 4.3.3 Global Hydromorphone Revenue Market Share by Type (2021-2032)
5 Hydromorphone Market by Application
  1. 5.1 Hydromorphone Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Hydromorphone Sales by Application
  5. 5.2.1 Global Hydromorphone Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Hydromorphone Sales by Application (2021-2032)
  7. 5.2.3 Global Hydromorphone Sales Market Share by Application (2021-2032)
  8. 5.3 Global Hydromorphone Revenue by Application
  9. 5.3.1 Global Hydromorphone Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Hydromorphone Revenue by Application (2021-2032)
  11. 5.3.3 Global Hydromorphone Revenue Market Share by Application (2021-2032)
6 Global Hydromorphone Sales by Region
  1. 6.1 Global Hydromorphone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hydromorphone Sales by Region (2021-2032)
  3. 6.2.1 Global Hydromorphone Sales by Region (2021-2026)
  4. 6.2.2 Global Hydromorphone Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hydromorphone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hydromorphone Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hydromorphone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hydromorphone Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hydromorphone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hydromorphone Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hydromorphone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hydromorphone Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hydromorphone Revenue by Region
  1. 7.1 Global Hydromorphone Revenue by Region
  2. 7.1.1 Global Hydromorphone Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hydromorphone Revenue by Region (2021-2026)
  4. 7.1.3 Global Hydromorphone Revenue by Region (2027-2032)
  5. 7.1.4 Global Hydromorphone Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hydromorphone Revenue (2021-2032)
  8. 7.2.2 North America Hydromorphone Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hydromorphone Revenue (2021-2032)
  11. 7.3.2 Europe Hydromorphone Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hydromorphone Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hydromorphone Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hydromorphone Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hydromorphone Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceuticals
  2. 8.1.1 Teva Pharmaceuticals Company Information
  3. 8.1.2 Teva Pharmaceuticals Business Overview
  4. 8.1.3 Teva Pharmaceuticals Hydromorphone Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceuticals Hydromorphone Product Portfolio
  6. 8.1.5 Teva Pharmaceuticals Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Hydromorphone Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Hydromorphone Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Hydromorphone Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Hydromorphone Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Hydromorphone Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Hydromorphone Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Hydromorphone Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Hydromorphone Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Fresenius
  32. 8.6.1 Fresenius Company Information
  33. 8.6.2 Fresenius Business Overview
  34. 8.6.3 Fresenius Hydromorphone Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fresenius Hydromorphone Product Portfolio
  36. 8.6.5 Fresenius Recent Developments
  37. 8.7 Watson Laboratories
  38. 8.7.1 Watson Laboratories Company Information
  39. 8.7.2 Watson Laboratories Business Overview
  40. 8.7.3 Watson Laboratories Hydromorphone Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Watson Laboratories Hydromorphone Product Portfolio
  42. 8.7.5 Watson Laboratories Recent Developments
  43. 8.8 Stada Arzneimittel
  44. 8.8.1 Stada Arzneimittel Company Information
  45. 8.8.2 Stada Arzneimittel Business Overview
  46. 8.8.3 Stada Arzneimittel Hydromorphone Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Stada Arzneimittel Hydromorphone Product Portfolio
  48. 8.8.5 Stada Arzneimittel Recent Developments
  49. 8.9 Purdue Pharma
  50. 8.9.1 Purdue Pharma Company Information
  51. 8.9.2 Purdue Pharma Business Overview
  52. 8.9.3 Purdue Pharma Hydromorphone Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Purdue Pharma Hydromorphone Product Portfolio
  54. 8.9.5 Purdue Pharma Recent Developments
  55. 8.10 Mundipharma
  56. 8.10.1 Mundipharma Company Information
  57. 8.10.2 Mundipharma Business Overview
  58. 8.10.3 Mundipharma Hydromorphone Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mundipharma Hydromorphone Product Portfolio
  60. 8.10.5 Mundipharma Recent Developments
  61. 8.11 Mallinckrodt
  62. 8.11.1 Mallinckrodt Company Information
  63. 8.11.2 Mallinckrodt Business Overview
  64. 8.11.3 Mallinckrodt Hydromorphone Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Mallinckrodt Hydromorphone Product Portfolio
  66. 8.11.5 Mallinckrodt Recent Developments
  67. 8.12 Lannett
  68. 8.12.1 Lannett Company Information
  69. 8.12.2 Lannett Business Overview
  70. 8.12.3 Lannett Hydromorphone Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Lannett Hydromorphone Product Portfolio
  72. 8.12.5 Lannett Recent Developments
  73. 8.13 KV Pharmaceutical
  74. 8.13.1 KV Pharmaceutical Company Information
  75. 8.13.2 KV Pharmaceutical Business Overview
  76. 8.13.3 KV Pharmaceutical Hydromorphone Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 KV Pharmaceutical Hydromorphone Product Portfolio
  78. 8.13.5 KV Pharmaceutical Recent Developments
  79. 8.14 Barr Pharmaceuticals
  80. 8.14.1 Barr Pharmaceuticals Company Information
  81. 8.14.2 Barr Pharmaceuticals Business Overview
  82. 8.14.3 Barr Pharmaceuticals Hydromorphone Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Barr Pharmaceuticals Hydromorphone Product Portfolio
  84. 8.14.5 Barr Pharmaceuticals Recent Developments
  85. 8.15 Apotex
  86. 8.15.1 Apotex Company Information
  87. 8.15.2 Apotex Business Overview
  88. 8.15.3 Apotex Hydromorphone Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Apotex Hydromorphone Product Portfolio
  90. 8.15.5 Apotex Recent Developments
  91. 8.16 Akorn
  92. 8.16.1 Akorn Company Information
  93. 8.16.2 Akorn Business Overview
  94. 8.16.3 Akorn Hydromorphone Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Akorn Hydromorphone Product Portfolio
  96. 8.16.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hydromorphone Value Chain Analysis
  2. 9.1.1 Hydromorphone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hydromorphone Production Mode & Process
  6. 9.2 Hydromorphone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hydromorphone Distributors
  9. 9.2.3 Hydromorphone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst